Medical Devices Startups

A digital health company building innovative medical device solutions with a focus on advanced clinical applications. The company combines strategic healthcare expertise with engineering capability to bring novel technologies to market.

1 investor

AEVA Digital is an integrated platform with embedded expert guidance and AI that manages cash-pay medical and wellness practices' entire operations, from patient acquisition through billing and retention. The system combines twenty years of industry expertise with machine learning to unify traditionally fragmented functions like marketing, scheduling, and analytics.

1 investor

AEYE Health makes AEYE-DS, an FDA-cleared autonomous AI system that screens for diabetic retinopathy using portable and tabletop retinal cameras, producing a diagnostic report in about a minute without physician interpretation. It is designed for primary care physicians to perform point-of-care screening and replace specialist referrals.

1 investor

Afimmune develops new medicines for rare and inflammatory diseases through drug discovery and development programs at various clinical and pre-clinical stages.

1 investor

Afrilens Tech manufactures advanced prescription ophthalmic lenses in Kenya through an in-house production facility, serving opticians, retail chains, hospitals, clinics, and distributors across East and Central Africa. The company eliminates import delays by producing precision lenses locally with full control over surfacing, coating, engraving, and quality control processes.

1 investor

Advanced Medical Solutions Austria is a medical device distributor that acquires and introduces innovative surgical instruments and techniques—focused on minimally invasive procedures—to hospitals and surgical practices in Austria and beyond. The company serves hospitals, purchasing organizations, and private practices across general surgery, cardiac/thoracic surgery, gynecology, and urology.

1 investor

Afynia develops diagnostic tools focused on women's health, with an emphasis on endometriosis detection through diagnostic biomarkers. The company operates a CLIA laboratory and works on molecular biology testing for reproductive health conditions.

1 investor

AFYX is a biopharmaceutical company focused on reformulation and repurposing of existing pharmaceuticals for conditions including head and neck cancer, labor induction, cluster headaches, and pain and addiction. The company operates across 46 global markets through direct operations and partnerships.

1 investor

Agar Scientific manufactures laboratory platform rockers for gentle mixing applications in research and clinical settings. The company offers compact and full-sized models designed for continuous operation in benchtop and incubator environments.

1 investor

AGC Biologics is a contract development and manufacturing organization (CDMO) providing biopharmaceutical manufacturing services including cell therapy, mammalian, and mRNA-LNP production. The company operates multiple sites globally and is expanding its Japan capabilities with a new GMP-ready facility in Yokohama launching in 2027.

1 investor

Agendia develops genomic technology and diagnostic tests for breast cancer patients. The company applies genomic science to improve treatment outcomes and quality of life for cancer patients.

1 investor

Agibot develops surgical robots and related technologies for minimally invasive procedures across urology, gynecology, general surgery, and thoracic surgery. The company's AGIBOT laparoscopic surgical robot has received regulatory approval in China and is being deployed in multiple clinical specialties.

1 investor

Agiliti provides medical and surgical equipment along with related services, including hospital beds and therapeutic surfaces, medical device rental, onsite equipment management, clinical engineering, and surgical technology services. It serves U.S. acute care facilities, government agencies, and medical device manufacturers.

1 investor

Ahead Simulations manufactures specialized simulation and testing hardware products, including ALEX and CARL systems with various configurations and accessories.

1 investor

AiD Medical develops health technologies, including AI and machine learning tools, aimed at improving health outcomes across the Global South.

1 investor

AI-Stroke develops AI-driven medical software for the diagnosis and management of stroke, analyzing neurovascular brain imaging to support clinicians' treatment decisions. The company serves stroke and cerebrovascular care providers in the healthcare and medical device industry.

1 investor

Aibion provides medical data services including annotation and segmentation of medical images, data and process mining, AI computer vision for diagnostic decision support, and medical software development and consulting. It serves healthcare organizations and medical professionals with analytics, business intelligence, and regulatory-compliant medical product design.

1 investor

AIDO develops a robotic add-on system, combining hardware and software, that attaches to existing endoscopes to assist endoscopists with complex, non-invasive procedures such as treating colorectal cancer and performing pancreatic biopsies. The company targets early diagnosis and treatment of digestive cancers in the medical device and endoscopy field.

1 investor

Advanced Image Enhancement develops proprietary wavelet-based digital image enhancement technology for medical imaging, particularly to improve visibility of subtle lesions in mammograms and other radiology images for physicians. The technology evolved from U.S. Navy research and complements existing imaging systems and AI applications in diagnostic imaging.

1 investor

AHI Group operates aesthetic medical hospitals and clinics in China, providing cosmetic surgery and aesthetic medicine services through facilities in Shenzhen and other locations.

1 investor

AIKON Health develops a wearable device solution for heart failure monitoring that measures vital parameters such as fluid retention, cardiac output, and stroke volume to help cardiologists and cardiology nurses manage patients and reduce hospital readmissions. The solution enables continuous tracking from hospital discharge through at-home care with digital biomarkers to identify early deterioration.

1 investor

Aimbient builds an ambient AI platform for procedural medicine that automatically captures clinical cases and generates actionable intelligence for healthcare teams to improve patient care and operational outcomes. The platform serves hospitals and health systems for case management and performance optimization.

1 investor

AIM Biotech develops organ-on-chip and 3D tissue culture platforms (idenTx, organiX, and Avatar) for drug discovery and preclinical research. The company provides tools for academic and pharmaceutical researchers to model human tissue microenvironments and accelerate therapeutic development.

1 investor

A Japanese company that supplies orthopedic and musculoskeletal medical devices, including internal fixation cables and plates, artificial hip joints, artificial ligaments, absorbable bone regeneration materials, hydroxyapatite bone graft substitutes, bone disinfection equipment, and diagnostic imaging fixation tools. Its products serve orthopedic surgery and sports medicine applications.

1 investor